期刊文献+

组织型激肽释放酶对脑缺血再灌注大鼠细胞凋亡和炎性反应的影响 被引量:2

The effect of TK on apoptosis and inflammatory reaction in rat models of cerebral ischemia-reperfusion
下载PDF
导出
摘要 目的探讨组织型激肽释放酶(TK)对脑缺血再灌注大鼠的治疗作用和对细胞凋亡、炎性反应的影响。方法将36只SD大鼠随机分为3组,A组:假手术;B组:生理盐水2ml·kg-1·d-1干预;C组:脑缺血再灌注后8h给予TK17.5×10-3U·kg-1·d-1治疗,每组12只。连续给药3天后分别进行神经功能缺损评分,脑梗死体积测定,梗死组织HE染色。对脑梗死组织进行TUNEL染色和细胞凋亡蛋白酶-3(caspase-3)、TNF-α、白细胞介素-1(IL-1)免疫组织化学检测。结果与A组和B组比较,C组能明显降低神经功能缺损,使脑梗死的体积变小(P<0.05);减轻脑梗死的病理改变;使缺血区内TUNEL、caspase-3、TNF-α、IL-1阳性细胞减少(P<0.05)。结论TK对脑缺血再灌注大鼠有治疗作用,能明显减轻缺血区内的细胞凋亡和炎性反应。 Objective To explore the therapeutic effectiveness of tissue kallikrein(TK) in rat models of ischemia-reperfusion induced by middle cerebral artery occlusion and the effect of TK on apoptosis and inflammatory reaction in the cerebral infarction. Methods Thirty-six rats were randomly divided into three groups. Group A underwent sham operation;group B was administrated with normal saline(2 ml· kg^-1·d^-1);group C was administrated with TK(17. 55〈10^-3U· kg^-1· d ^-1)after ischemia-reperfusion for 8 hours. All rats received intraperitoneal injection for three days. After three days, neurological function was appraised and infarct volume was determined. The pathology of ischemic tissue was examined. TUNEL staining and immunohistochemical examination of caspase-3,TNF-α,IL-1 in ischemic tissue were carried out. Results Compared with group A and group B,deficit of neurological function and the infarct volume (P 〈0.05) were reduced significantly, pathological change in ischemic tissue was improved, the positive cells of TUNEL staining, caspase-3, TNF-α and IL-1 in ischemic tissue were reduced in group C (P〈0.05). Conclusion TK has therapeutical effect on cerebral infarction and can obviously relieve the apoptosis and inflammatory reaction in the cerebral infarct area.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2008年第9期707-709,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 组织激肽释放酶类 脑缺血 再灌注 细胞凋亡 tissue kallikreins brain ischemia reperfusion apoptosis
  • 相关文献

参考文献8

  • 1Emami N,Diamandis EP. Human tissue kallikreins:A road under construction. Clin Chem Acta, 2007,381: 78-84.
  • 2Longa EZ, Weinstein PR, Carlson L, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989,20:84-91.
  • 3Chen JL, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cell after cerebral ischemia in rats. Stroke,2001,32 : 1005-1011.
  • 4Gerriets T, Li F, Silva MD, et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods, 2003,122: 201- 211.
  • 5Lumenta DB, Plesnila N, Klasnera B, et al. Neuroprotective effects of a postischemic treatment with a bradykinin B2 recep tor antagonist in a rat model of temporary focal cerebral ischemia. Brain Res, 2006,1069 :227-234.
  • 6Xia CF,Yin H,Yao YY,et al. Kallikrein protect against ischemia stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Human Gene Therapy 2006,17:206-219.
  • 7Zheng Z, Yenari MA. Post-isehemie inflammation: molecular mechanisms and therapeutic implications. Neurol Res, 2004, 26: 884-892.
  • 8Trendelenburg G. Acute neurodegeneration and the inflammasome:central processor for danger signals and the inflammatory response? J Cereb Blood Flow Metab,2008,28:867-881.

同被引文献19

  • 1李彦玲,张新萍,种莉,刘红艳.急性脑梗死患者外周血IL-6、IL-8水平表达的临床研究[J].陕西医学杂志,2005,34(8):974-975. 被引量:3
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15722
  • 4Yousef GM,Kishi T,Diamandis EP. Role of kallikrein enzymes in the central nervous system[J]. Clin Chim Acta, 2003,329:1- 8.
  • 5Groger M,Lebesgue D,Pruneau D, et al. Release of bradykinin and expression of kinin. B2 receptors in the brain : role for cell death and brain edema formation after forcal cerebral isehemia in mice[J]. J Cereb Blood Flow Metab, 2005,25 : 978-989.
  • 6Wagner S, Kalb P, Lukosava M, et al. Activation of the tissue kallkrein-kinin system in stroke[J]. J Neurol Sci, 2002,202: 75-76.
  • 7Chao J. Kallkrein-kinin in stroke, carcliovascular and renal disease [J]. Exp Dhysiol,2005,90(1):291-298.
  • 8Xia CF, Yin H, BrolonganCV, et al. Kallikrein gene thransfer protects against ischemic stroke by prmoting glial cell migration and inhibiting apoptosis [J ] . Hypertention, 2004,43 (2) : 452- 459.
  • 9Emanueli C, Madeddu P. Angiogenesis therapy with human tissue kallkrein-kinin for the treatment of ischemlc dieases [J]. Arch Malcoeur, 2004,97 : 679-687.
  • 10Xia CF,Yin H, Yao YY, et al . Kallkrein protects against ischemic stroke by Inhibiting apoptosis and Inflamation and prmoting angiogenesis and neurogenesis [J]. Human Gene Therapy,2006,17(2) ..206-219.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部